Page last updated: 2024-11-06

sabeluzole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

sabeluzole: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID59823
CHEMBL ID549671
CHEBI ID177731
SCHEMBL ID51527
MeSH IDM0155435

Synonyms (32)

Synonym
CHEBI:177731
1-[4-[1,3-benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(4-luorophenoxy)propan-2-ol
r-58735
sabeluzole
sabeluzole (usan/inn)
D05780
104383-17-7
r 58735
(+-)-4-(2-benzothiazolylmethylamino)-alpha-((p-fluorophenoxy)methyl)-1-piperidineethanol
1-piperidineethanol, 4-(2-benzothiazolylmethylamino)-alpha-((4-fluorophenoxy)methyl)-, (+-)-
1-[4-[1,3-benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(4-fluorophenoxy)propan-2-ol
CHEMBL549671
sabeluzole [usan:inn:ban]
a998504xy4 ,
unii-a998504xy4
SCHEMBL51527
104153-38-0
1-piperidineethanol, 4-(2-benzothiazolylmethylamino)-a-[(4-fluorophenoxy)methyl]-;1-piperidineethanol, 4-(2-benzothiazolylmethylamino)-a-[(4-fluorophenoxy)methyl]-
Q7396032
1-piperidineethanol,4-(2-benzothiazolylmethylamino)-a-[(4-fluorophenoxy)methyl]-
DTXSID60869418
1-piperidineethanol, 4-(2-benzothiazolylmethylamino)-.alpha.-((4-fluorophenoxy)methyl)-, (+/-)-
sabeluzole [inn]
1-piperidineethanol, 4-(2-benzothiazolylmethylamino)-.alpha.-((4-fluorophenoxy)methyl)-
sabeluzole [usan]
sabeluzole [mi]
sabeluzole [who-dd]
(+/-)-4-(2-benzothiazolylmethylamino)-.alpha.-((p-fluorophenoxy)methyl)-1-piperidineethanol
sabeluzole [mart.]
AKOS040749397
HY-105022
CS-0024717

Research Excerpts

Treatment

Sabeluzole treatment could be beneficial in reducing the deleterious effect of diabetes on sexual functions. Treatment was not effective in the overall group compared to the placebo-treated group, nor in any subgroup stratified by epsilon 4 allele count.

ExcerptReferenceRelevance
"Sabeluzole treatment could be beneficial in reducing the deleterious effect of diabetes on sexual functions."( The effect of diabetes on sexual behavior and reproductive tract function in male rats.
Elhilali, MM; Gagnon, C; Hassan, AA; Hassouna, MM; Taketo, T, 1993
)
1.01
"Sabeluzole treatment was not effective in the overall group compared to the placebo-treated group, nor in any subgroup stratified by epsilon 4 allele count."( APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
Aerssens, J; Geerts, H; Konings, F; Lilienfeld, S; Parys, W; Raeymaekers, P,
)
0.85

Pharmacokinetics

ExcerptReferenceRelevance
"The terminal half-life of sabeluzole was significantly prolonged in subjects with severe hepatic dysfunction vs healthy subjects (respectively 39."( Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers.
Blin, O; Bouhours, P; Lacarelle, B; Le Moing, JP; Levron, JC; Micallef, J; Nataf, MB; Pageaux, GP, 2001
)
0.93

Dosage Studied

ExcerptRelevanceReference
" Scopolamine hydrobromide reinstated contralateral placing errors in infarcted rats at a dosage that did not affect neurologically intact rats."( Ionic channels, cholinergic mechanisms, and recovery of sensorimotor function after neocortical infarcts in rats.
De Ryck, M; Duytschaever, H; Janssen, PA; Pauwels, PJ, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzothiazoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID660336Half life in human liver microsomes assessed as CYP2C19-mediated parent compound depletion at 1 uM2011ACS medicinal chemistry letters, Aug-11, Volume: 2, Issue:8
Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design.
AID660332Half life in human liver microsomes assessed as CYP2D6-mediated parent compound depletion at 1 uM2011ACS medicinal chemistry letters, Aug-11, Volume: 2, Issue:8
Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design.
AID660333Half life in human liver microsomes assessed as CYP2B6-mediated parent compound depletion at 1 uM2011ACS medicinal chemistry letters, Aug-11, Volume: 2, Issue:8
Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design.
AID660334Half life in human liver microsomes assessed as CYP2C8-mediated parent compound depletion at 1 uM2011ACS medicinal chemistry letters, Aug-11, Volume: 2, Issue:8
Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design.
AID660335Half life in human liver microsomes assessed as CYP2C9-mediated parent compound depletion at 1 uM2011ACS medicinal chemistry letters, Aug-11, Volume: 2, Issue:8
Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design.
AID660338Clearance in human liver microsomes at 1 uM2011ACS medicinal chemistry letters, Aug-11, Volume: 2, Issue:8
Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design.
AID660331Half life in human liver microsomes assessed as CYP3A4-mediated parent compound depletion at 1 uM2011ACS medicinal chemistry letters, Aug-11, Volume: 2, Issue:8
Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design.
AID660337Half life in human liver microsomes assessed as CYP1A2-mediated parent compound depletion at 1 uM2011ACS medicinal chemistry letters, Aug-11, Volume: 2, Issue:8
Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design.
AID419526Volume of distribution at steady state in human at 10 mg, iv2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (12.90)18.7374
1990's22 (70.97)18.2507
2000's4 (12.90)29.6817
2010's1 (3.23)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials12 (31.58%)5.53%
Reviews2 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (63.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]